The Rx Recap: November 16-21

Welcome to this week’s roundup of the most insightful and impactful articles from the sister publications of Dermatology Times, all under One MJH Life Sciences. Our network brings together expert perspectives, clinical advancements, and industry updates to keep clinicians informed and ahead of the curve. From cutting-edge treatments to practice management strategies, here’s a look at the top stories shaping the field of medicine.

Innovative Delivery Technologies That Enhance Bioavailability and Stability

Reported by Nutritional Outlook, next-generation nutraceutical delivery systems are rapidly transforming product formulation, offering improved stability, bioavailability, and consumer-friendly dosing across formats like hydrogels, liposomes, micelles, and advanced capsules. New technologies such as plant-based hydrogel systems, capsule-in-capsule formats, and micellar and liposomal structures are helping formulators solve long-standing challenges with poorly soluble, unstable, or pH-sensitive ingredients—from probiotics to curcumin and herbal phytonutrients—while enabling lower doses, better absorption, and greater versatility across supplements, beverages, gummies, and functional foods.

Federal Medical Recommendation Changes Cause Confusion for Patients, Health Care Providers

Reported by Drug Topics, lingering distrust in federal health agencies such as the CDC and HHS has become a major challenge in the post-COVID landscape, as shifting and sometimes conflicting guidance—both between institutions and within them—fuels confusion among clinicians and patients alike. Critics note that updates based on selective or weak data interpretations have eroded confidence, especially as evolving recommendations affect access to vaccines and treatments for vulnerable populations. As social health commentator Morgan McSweeney, PhD, cautions, revising guidance with emerging evidence is expected, but using data to reinforce preconceived positions undermines scientific integrity and weakens the public’s trust in the system.

CDC Updates Website, Opens Door for Autism and Vaccines Link

Recent changes to the CDC’s “Autism and Vaccines” webpage—now suggesting that studies have not ruled out a possible link between infant vaccines and autism—have sparked intense national backlash from pediatric leaders and vaccine experts. The American Academy of Pediatrics condemned the update as the promotion of false, debunked claims, emphasizing that more than 40 high-quality studies involving over 5.6 million people show no connection between vaccines and autism. The conflicting language across CDC pages, combined with policy shifts under HHS leadership, has fueled concern among clinicians about rising vaccine hesitancy and potential harm to public health. Experts interviewed by Contemporary Pediatrics stress that routine immunization remains safe, effective, and essential—and warn that undermining science-based vaccine guidance risks a dangerous return to the era of widespread, preventable childhood disease.

FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer

Reported by CURE, the FDA has approved Keytruda (with or without berahyaluronidase) plus Padcev as neoadjuvant and adjuvant therapy for adults with muscle-invasive bladder cancer ineligible for cisplatin. The KEYNOTE-905/EV-303 trial showed the combination significantly improved event-free and overall survival versus surgery alone. Padcev, an antibody-drug conjugate targeting NECTIN4 and TROP2, delivers chemotherapy directly to tumor cells, while Keytruda carries immune-related risks. The regimen combines pre- and post-surgery cycles to maximize efficacy and minimize harm to healthy tissue.

The Ultimate Guide to Neurotoxins for Mature Skin

Reported by New Beauty, dermatologists emphasize that neurotoxin treatments for mature skin should focus on precision and lower dosing to match age-related changes in facial structure and muscle strength. Experts note that over-treating areas like the forehead or eyes can cause heaviness, unnatural expressions, or dropped brows, while strategic use on the glabella, neck, jawline, and chin continues to deliver natural, refreshed results. The key, they say, is balance—treating smaller, spread-out muscles with careful timing and moderation to maintain a youthful, harmonious appearance without overtreatment.

Want to read more on specialty care, pharmacy, industry sciences, and more? Check out MJH Life Sciences full list of brands here.